Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies-Reference-Cited by-同舟云学术

Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies

Published:1995-01 Issue:1-6 Volume:103 Page:20-24
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:

Author:

Nedergaard LOTTE,Haerslev TORBEN,Jacobsen GRETE KRAG

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1699-0463.1995.tb01074.x/fullpdf

Reference18 articles.

1. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumour differentiation;Andersen;Eur. J. Cancer Clin. Oncol.,1988

2. Immunohistochemical estrogen receptor determination in paraffin-embedded tissue-prediction of response to hormonal treatment in advanced breast cancer;Andersen;Cancer,1989

3. Estrogen receptor in primary breast cancer estimated in paraffin-embedded tissue. A study of its usefulness compared to dextran-coated charcoal assay;Andersen;Acta Oncol.,1991

4. Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer;Castagnetta;Eur. J. Cancer Clin. Oncol.,1987

5. Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor;Davis;Eur. J. Cancer Clin. Oncol.,1984

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases;Clinical & Experimental Metastasis;2023-07-01

2. Discordance in receptor status between primary and metastatic breast cancer and overall survival: A single-center analysis;Annals of Diagnostic Pathology;2022-12

3. Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers;Frontiers in Oncology;2021-11-03

4. Expression of Biomarkers Estrogen Receptor, Progesterone Receptor, HER2 in Primary Breast Tumour and Synchronous Metastatic Axillary Lymph Node;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2021

5. Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases;Oncology Letters;2020-09-21